ECSP045080A - USO DE (11b,17b)-11-(1,3-BENZODIOXOL-5-IL)-17-HIDROXI-17-(1-PROPINIL)-ESTRA-4,9-DIEN-3-ONA EN EL TRATAMIENTO DEL DESORDEN DEPRESIVO MAYOR - Google Patents
USO DE (11b,17b)-11-(1,3-BENZODIOXOL-5-IL)-17-HIDROXI-17-(1-PROPINIL)-ESTRA-4,9-DIEN-3-ONA EN EL TRATAMIENTO DEL DESORDEN DEPRESIVO MAYORInfo
- Publication number
- ECSP045080A ECSP045080A EC2004005080A ECSP045080A ECSP045080A EC SP045080 A ECSP045080 A EC SP045080A EC 2004005080 A EC2004005080 A EC 2004005080A EC SP045080 A ECSP045080 A EC SP045080A EC SP045080 A ECSP045080 A EC SP045080A
- Authority
- EC
- Ecuador
- Prior art keywords
- estra
- benzodioxol
- dien
- treatment
- propinil
- Prior art date
Links
- 230000003001 depressive effect Effects 0.000 title 1
- DFELGYQKEOCHOA-BZAFBGKRSA-N (8s,11r,13s,14s,17s)-11-(1,3-benzodioxol-5-yl)-17-hydroxy-13-methyl-17-prop-1-ynyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one Chemical compound C1=C2OCOC2=CC([C@@H]2C3=C4CCC(=O)C=C4CC[C@H]3[C@@H]3CC[C@@]([C@]3(C2)C)(O)C#CC)=C1 DFELGYQKEOCHOA-BZAFBGKRSA-N 0.000 abstract 2
- 208000020401 Depressive disease Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940126013 glucocorticoid receptor antagonist Drugs 0.000 abstract 1
- 239000003850 glucocorticoid receptor antagonist Substances 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente invención se refiere al uso de (11b,17b)-11-(1,3-benzodioxol-5-il)-17-hidroxi-17-(1-propinil)-estra-4,9-dien-3-ona (Org 34517), antagonista de los receptores glucocorticoides, para la preparación de un medicamento para el tratamiento de la depresión, así como a preparaciones farmacéuticas de Org 34517 para dicho uso.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01204072 | 2001-10-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP045080A true ECSP045080A (es) | 2004-06-28 |
Family
ID=8181136
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EC2004005080A ECSP045080A (es) | 2001-10-26 | 2004-04-23 | USO DE (11b,17b)-11-(1,3-BENZODIOXOL-5-IL)-17-HIDROXI-17-(1-PROPINIL)-ESTRA-4,9-DIEN-3-ONA EN EL TRATAMIENTO DEL DESORDEN DEPRESIVO MAYOR |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US20040266863A1 (es) |
| EP (2) | EP1441739B1 (es) |
| JP (1) | JP4647909B2 (es) |
| KR (1) | KR20050038580A (es) |
| CN (1) | CN100531738C (es) |
| AT (2) | ATE420649T1 (es) |
| AU (1) | AU2002348996B2 (es) |
| BR (1) | BR0213466A (es) |
| CA (1) | CA2463446C (es) |
| CY (1) | CY1110173T1 (es) |
| DE (2) | DE60230936D1 (es) |
| DK (1) | DK1652526T3 (es) |
| EC (1) | ECSP045080A (es) |
| ES (1) | ES2319563T3 (es) |
| HR (1) | HRP20040370B1 (es) |
| HU (1) | HUP0500070A3 (es) |
| IL (2) | IL161248A0 (es) |
| IS (1) | IS2702B (es) |
| MX (1) | MXPA04003781A (es) |
| NO (1) | NO332978B1 (es) |
| NZ (1) | NZ532429A (es) |
| PL (1) | PL206687B1 (es) |
| PT (1) | PT1652526E (es) |
| RU (1) | RU2302245C2 (es) |
| WO (1) | WO2003037354A1 (es) |
| ZA (1) | ZA200403088B (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050080061A1 (en) * | 2003-07-23 | 2005-04-14 | Corcept Therapeutics, Inc. | Antiglucocorticoid therapy for the prevention of neurological damage in premature infants |
| AU2011236053B2 (en) * | 2004-11-19 | 2014-06-26 | Merck Sharpe & Dohme B.V. | Drug combination comprising a selective serotonin reuptake inhibitor and a glucocorticoid receptor antagonist for the treatment of depression |
| CN101060860B (zh) * | 2004-11-19 | 2013-07-17 | Msd欧斯股份有限公司 | 用于治疗抑郁症的包含选择性5-羟色胺再摄取抑制剂和糖皮质激素受体拮抗剂的药物组合 |
| EP2012796A4 (en) * | 2006-05-02 | 2010-08-11 | Corcept Therapeutics Inc | USE OF GLUCOCORTICOID TYPE II RECEPTOR ANTAGONISTS TO TREAT PATIENT DEPRESSION WITH IL-2 |
| US8658128B2 (en) | 2011-02-03 | 2014-02-25 | Pop Test Cortisol Llc | System and method for diagnosis and treatment |
| EP2699245A4 (en) * | 2011-04-18 | 2014-12-10 | Pop Test Cortisol Llc | TREATMENT AGAINST HAIR LOSS |
| US8986677B2 (en) * | 2012-07-30 | 2015-03-24 | Pop Test Cortisol Llc | Therapeutic compositions and methods |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4814333A (en) * | 1987-07-28 | 1989-03-21 | The Trustees Of Dartmouth College | Method for treatment of hypercortisolemic, depressed patients |
| DE4447401A1 (de) * | 1994-12-23 | 1996-07-04 | Schering Ag | 14,17-C¶2¶-überbrückte Steroide |
| IL118974A (en) * | 1995-08-17 | 2001-09-13 | Akzo Nobel Nv | History 11 - (Transformed Phenyl) - Astra - 4, 9 - Diane, their preparation and pharmaceutical preparations containing them |
| DE19727772A1 (de) * | 1997-06-30 | 1999-01-28 | Forschungszentrum Juelich Gmbh | Magnetflußsensor mit ringförmiger Sonde |
| ATE332696T1 (de) * | 1997-10-06 | 2006-08-15 | Univ Leland Stanford Junior | Methode zur behandlung von durch glycocorticoidstörungen verursachten psychosen |
| CA2440605C (en) * | 2001-03-23 | 2012-01-10 | Corcept Therapeutics, Inc. | Methods for treating stress disorders using glucocorticoid receptor-specific antagonists |
| WO2002096433A1 (en) * | 2001-05-04 | 2002-12-05 | Corcept Therapeutics, Inc. | Methods for treating delirium using glucocorticoid receptor-specific antagonists |
| CA2459033C (en) * | 2001-08-31 | 2012-05-22 | Corcept Therapeutics, Inc. | Methods for inhibiting cognitive deterioration in adults with down's syndrome |
-
2002
- 2002-10-21 KR KR1020047006050A patent/KR20050038580A/ko not_active Ceased
- 2002-10-21 RU RU2004116082/15A patent/RU2302245C2/ru not_active IP Right Cessation
- 2002-10-21 MX MXPA04003781A patent/MXPA04003781A/es active IP Right Grant
- 2002-10-21 PL PL369261A patent/PL206687B1/pl not_active IP Right Cessation
- 2002-10-21 WO PCT/EP2002/011732 patent/WO2003037354A1/en not_active Ceased
- 2002-10-21 IL IL16124802A patent/IL161248A0/xx unknown
- 2002-10-21 JP JP2003539697A patent/JP4647909B2/ja not_active Expired - Fee Related
- 2002-10-21 US US10/493,981 patent/US20040266863A1/en not_active Abandoned
- 2002-10-21 PT PT06101005T patent/PT1652526E/pt unknown
- 2002-10-21 CN CNB028210417A patent/CN100531738C/zh not_active Expired - Fee Related
- 2002-10-21 EP EP02781273A patent/EP1441739B1/en not_active Expired - Lifetime
- 2002-10-21 AT AT06101005T patent/ATE420649T1/de active
- 2002-10-21 DE DE60230936T patent/DE60230936D1/de not_active Expired - Lifetime
- 2002-10-21 EP EP06101005A patent/EP1652526B1/en not_active Expired - Lifetime
- 2002-10-21 HU HU0500070A patent/HUP0500070A3/hu unknown
- 2002-10-21 ES ES06101005T patent/ES2319563T3/es not_active Expired - Lifetime
- 2002-10-21 HR HRP20040370AA patent/HRP20040370B1/xx not_active IP Right Cessation
- 2002-10-21 BR BR0213466-7A patent/BR0213466A/pt not_active IP Right Cessation
- 2002-10-21 CA CA2463446A patent/CA2463446C/en not_active Expired - Fee Related
- 2002-10-21 AT AT02781273T patent/ATE317700T1/de active
- 2002-10-21 AU AU2002348996A patent/AU2002348996B2/en not_active Ceased
- 2002-10-21 DK DK06101005T patent/DK1652526T3/da active
- 2002-10-21 NZ NZ532429A patent/NZ532429A/en not_active IP Right Cessation
- 2002-10-21 DE DE60209248T patent/DE60209248D1/de not_active Expired - Lifetime
-
2004
- 2004-03-31 IS IS7204A patent/IS2702B/is unknown
- 2004-04-01 IL IL161248A patent/IL161248A/en not_active IP Right Cessation
- 2004-04-22 ZA ZA200403088A patent/ZA200403088B/en unknown
- 2004-04-23 NO NO20041651A patent/NO332978B1/no not_active IP Right Cessation
- 2004-04-23 EC EC2004005080A patent/ECSP045080A/es unknown
-
2009
- 2009-02-02 CY CY20091100116T patent/CY1110173T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP034772A (es) | Antagonistas de mch y su uso en el tratamiento de obesidad | |
| AR126239A1 (es) | Región 5 no traducida y región 3 no traducida no naturales y uso de estas | |
| ES2156603T3 (es) | Medicamentos a base de una mezcla sinergetica de metronidazol y de clindamicina. | |
| AR028948A1 (es) | Compuestos novedosos | |
| ECSP083351A (es) | Composiciones farmacéuticas | |
| AR057060A1 (es) | Composiciones de tanaproget que contienen etinil estradiol | |
| BRPI0408547A (pt) | formulação para um inalador com dosador usando hidro-flúor-alcanos como propelentes | |
| CR8428A (es) | Agente endoparasiticidas para la administracion topica | |
| CR7611A (es) | Uso de derivados de cilotiocarbamato en tratamiento de condiciones relacionadas con la hormona | |
| CR11345A (es) | Compuestos de [3,2-c] pirazol esteroides con actividad glucocorticoide | |
| UY33470A (es) | Derivados de 6,7-dihidro-5h-benzo[7]anulenos, métodos para su preparación, preparaciones farmacéuticas que los contienen y su uso para la preparación de medicamentos | |
| ECSP034811A (es) | Derivados heterocicliloxi-, -tioxi - y - aminobenzazole tales como ligandos 5-hidroxitriptamina-6 | |
| AR040130A1 (es) | Esteres de etonogestrel, su uso como anticopceptivo y para el tratamiento de desordenes ginecologicos | |
| CY1110173T1 (el) | Χρηση της (11 beta, 17beta)-11-(1,3-benzodioxol-5-yl)-17-hydroxy-17-(1-propynyl)-estra-4,9-dien-3-one στη θεραπεια μειζωνος καταθλιπτικης διαταραχης | |
| UY29320A1 (es) | 18-metil-19-nor-17-pregn-4-en-21, 17-carbolactonas, así como preparaciones farmacéuticas que las contienen | |
| BR0208336A (pt) | Novas amidas, preparação e uso terapêutico como moduladores de atividade de receptor-ccr | |
| CL2010001471A1 (es) | Un compuestos 2-fluoro-11-(piperazin-1.il) dibenzo´1,4 tiazepina, inhibidores net y antagonista moderado d2; procedimiento de preparacion del mismo; composicion farmaceutica; y uso en el tratamiento de trastornos psiquiatricos, entre otras enfermedades.. | |
| UY28334A1 (es) | Composicion que comprende antagonistas de receptores de progesterona y antiestrógenos puros para la profilaxis y el tratamiento de enfermedades dependientes de hormonas. | |
| AR018313A1 (es) | Kit anticonceptivo que comprende medios para la administracion diaria de un agente anticonceptivo, uso de un compuesto esteroide que tiene un perfil deactividad que combina inherentemente las actividades progestagenicas y estrogenicas y un metodo anticonceptivo | |
| CL2007002788A1 (es) | Un compuesto derivado de (cis)-8-fluorodibenzo[b,f]pirido[1,2-d]oxazepin-1-amina, modulador de los receptores de progesterona; composicion farmaceutica; y uso como anticonceptivo, para la terapia de reemplazo hormonal o para el tratamiento de un tras | |
| GT200600270A (es) | Uso de moduladores no esteroides de receptores de progesterona | |
| UY29861A1 (es) | Uso de valerato de estradiol en combinación con dienogest para la terapia oral de la hemorragia uterina disfuncional unida con una anticoncepcion oral | |
| AR026913A1 (es) | Analogos de (1s-cis)-4-(2-amino-9h-purin-9-il)-2-ciclopenten-1-metanol para uso en el tratamiento de infecciones virales | |
| BR0311209A (pt) | Método de produção de unidades de dosagem farmacêuticas para administração oral, uso de etonogestrel, e, tablete | |
| ECSP993057A (es) | Tetrahidro -3-furanil (1s,2r)-3-[[(4-aminofenil] sulfonil)] (isobutil) amino] -1- bencil-2 - (fosfonooxi) propilcarbamato de calcio |